Efavirenz (Sustiva, Stocrin)

Better Late Than Never: Efavirenz Dose Optimization

After a Study Suggests That We've Been Using Too High a Dose of Efavirenz for a Decade and a Half, the Move Toward Scaling Up a Lower and More Cost-Effective One Faces Some Hurdles

    Approaches to HIV Treatment Optimization
    Approaches to HIV Treatment Optimization Adapted from: Clayden P. Retrofitting for purpose: treatment optimization. In: Clayden P, Harrington M, Swan T, et al.; i-Base/Treatment Action Group.
    2013 pipeline report. New York: Treatment Action Group; 2013.

    Tim Horn

    Polly Clayden

    Treatment Action Group

    Treatment Action Group